Reuters logo
BRIEF-Glenmark Pharmaceuticals gets ANDA approval for indomethacin extended-release capsules USP, 75 mg
June 27, 2017 / 3:21 AM / 6 months ago

BRIEF-Glenmark Pharmaceuticals gets ANDA approval for indomethacin extended-release capsules USP, 75 mg

June 27 (Reuters) - Glenmark Pharmaceuticals Ltd

* Says Glenmark Pharmaceuticals receives ANDA approval for indomethacin extended-release capsules USP, 75 mg Source text - (bit.ly/2tPUBQk) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below